Some of the molecules that provide trophic support for the regrowing nerve fibres have been identified, including nerve growth factor (NGF) (Heumann et al. 1987) and glial maturation factor beta (Bosch et al. 1989) . Another class of molecules show changes in their rates of synthesis during regeneration, including both proteins (Skene & Shooter 1983; Muller et al. 1986 ) and mRNA species (Trapp et al. 1988; Meier et al. 1989) .
To better understand nerve regeneration, we have taken two, parallel molecular approaches to study the events associated with regeneration. The first of these is to study in detail the mechanism of action of a molecule that has been implicated in the regeneration process, nerve growth factor. The second approach is to identify novel gene sequences which are regulated during regeneration. Once the genes are isolated, it will be possible to test for functional roles of the encoded proteins during regeneration. Results from the two approaches are presented in this paper.
STRUCTURE AND FUNCTION ANALYSIS OF THE NGF RECEPTOR
The role of NGF in the development and survival of peripheral sensory and sympathetic neurons has been well characterized (Levi-Montalcini 1987) . Studies have also suggested a role for NGF in the development and maintenance of cholinergic neurons in the mam malian forebrain (Williams et al. 1986) . With regard to regeneration, the levels of NGF mRNA and protein synthesized by the non-neuronal cells of the distal nerve increase markedly after nerve injury, and only decline when axonal regrowth to the muscle is complete (Heumann et al. 1987 £) . This local supply of NGF serves to rapidly re-establish the critical retrograde flow of NGF in the neurons (Korsching & Thoenen 1983) after injury, and, since the synthesis of the NGF receptor (NGFR) in neurons is regulated by NGF (Lindsay et al. 1990) , to maintain the level of neuronal NGFR. Recent studies have also shown that Schwann cells in rat sciatic nerve express high levels of the lowaffinity NGFR following nerve crush or transection (Taniuchi et al. 1986; Heumann et al. 1987 ). This f To whom correspondence should be sent. Printed in Great Britain expression is repressed once contact is re-established between the Schwann cells and the regenerating axons. These low-affinity receptors may bind the NGF which is synthesized by non-neuronal cells distal to a peripheral nerve injury, and create a localized source of NGF on the surface of the Schwann cells over which the advancing neuronal growth cone migrates .
(a) The NGF receptor
The first step in the mechanism of action of NGF is the interaction of NGF with its specific receptor on responsive cells or cell lines. There are two types or states of NGFR as determined by binding studies (Sutter et al. 1979) . On sensory and sympathetic neurons, these receptors are described as high affinity (HNGFR, Kd = 10 pM), and low affinity (LNGFR, Kd = 1 nM), respectively. Although the NGFRs in PC 12 cells differ less in their Kd's, they share many features of the receptors on primary neurons, including a slower rate of dissociation of NGF from the HNGFR compared to the LNGFR (Vale & Shooter 1985) . suggests that the HNGFR comprises the LNGFR complexed with an additional cytoplasmic or mem brane-associated protein or proteins (Hosang & Shooter 1985; Hempstead et al. 1989) . The LNGFR has been cloned in rat , chicken (Large et al. 1989) , and human , and the three receptors share considerable homology. Details of the mechanism of NGF binding to the LNGFR have been examined by studying the in teraction of NGF with appropriate mutants of the receptor. In this approach, mutations are made in the cDNA encoding the NGF receptor, the mutant cDNAs are then expressed in cell lines that do not normally express the NGFR, and the effects of the mutations on the ability of NGF to bind to the receptor are determined. By using this approach, it should be possible to identify the amino-acid residues that are involved in NGF binding and subsequent signal transduction events. The importance of defining the NGF binding site is highlighted by the recent isolation of the genes for two related neurotrophic factors, brainderived neurotrophic factor (BDNF, Leibrock et al. 1989) , and neurotrophin-3 (NT-3, Ernfors et al. 1990 ). Both of these factors have been shown to compete with NGF for binding to the LNGFR (Rodriguez-Tebar et al. 1990; Ernfors et al. 1990 ). Since these factors have different biological effects in different tissues (Davies 1988) , it is essential that the binding of these factors to LNGFR is understood, to determine the specificity of action of these different neurotrophic factors.
The structure of NGFR protein can be divided into four domains. The first domain contains approximately 160 amino-acid residues, 24 of which are cysteine residues. The cysteine-rich sequence can be divided into .four blocks each containing six cysteine residues. The blocks are numbered 1-4, with block 1 representing the cysteine-rich block closest to the amino terminus of the protein. Blocks one and two are 83% homologous between species, while blocks 3 and 4 are, respectively, 63 % and 64 % homologous between species. Another striking aspect of the cysteine-rich sequence is the large number of negatively charged amino acids. In the rat cDNA, the net charge for blocks 1, 2, 3 and 4, are -1, -6, -5, and -8, respectively. The NGF protein is very basic with a pH of 9.2 (Greene et al. 1971) . T herefore, the charge interactions between a positively ^ charged NGF molecule and a negatively charged receptor molecule may play an important role in the x binding process. £ The next structural motif of the receptor is approxi-3 mately 60 amino-acid residues in length, and separates the cysteine-rich sequence from the membraneo spanning region. This region's main characteristic is t he presence of a number of serine and threonine amino § acid residues, which are potential sites for O-linked glycosylation. After this region, comes an approximate 20 amino-acid residue region that contains the re ceptor's single membrane spanning domain. The last region is approximately 150 amino acid residues in length, and contains the intracellular domain which is presumably involved in signal transduction.
(b) The NGF binding dom ain o f the LNGFR
The importance of the extracellular region of the NGFR for NGF binding was shown by the inability of NGF to bind to PC 12 cells which had been treated with trypsin (Schechter & Both well 1981) . Several studies suggest that the cysteine-rich sequences within the extracellular domain contribute to NGF binding. Sehgal and co-workers (1989) cotransfected genomic sequences, encoding the human LNGFR, into mouse fibroblasts and obtained expression of a deleted form of the receptor. The mutant receptors bound NGF, but at a reduced level compared to the wild type receptor. SI analysis suggested that the first 40 amino acids of the cysteine-rich sequence of the receptor were missing from the mutant. A truncated form of the low-affinity receptor is secreted into the extracellular media of cultured Schwann cells, PC 12 cells and superior cervical ganglia neurons, as well as the plasma and urine of normal rats . Isolation and analysis of this truncated form revealed that it could bind NGF (Zupan et al. 1989) . However, the carboxy terminus of the deleted receptor has not been determined. A soluble, recombinant form of the human NGF receptor, containing the cysteine-rich sequences and an additional 51 amino-acid residues, was expressed in the baculovirus expression system, and this truncated form of the receptor also bound NGF (Vissavajjhala & Ross 1990) . Taken together, these results suggest that the cysteine-rich sequences contribute to the binding of NGF.
To test whether the intracellular region of the LNGFR is important for NGF binding, for example, by stabilizing the extracellular domain, the first receptor mutation in this study was devised to remove the intracellular region. The mutant pNGFRt256 (figure 1) retained only 16 amino-acid residues of the intracellular domain. This construct was transfected into mouse fibroblasts. Cells that were transfected with the full-length receptor cDNA (wt NGFR) expressed a receptor protein with an apparent molecular weight of 81000, while cells transfected with the truncated cDNA clone expressed a receptor with an apparent molecular weight of 67000. Not only did NGF bind to the truncated form of the receptor ( . 45 000 receptors per cell), but it also had the same binding constant {ca. 1 nM) as the full-length receptor. Therefore, all, or at least most of the essential components for binding of NGF to the NGFR are contained within the first 256 amino-acid residues of the protein. Similar results have recently been reported for the human LNGFR (Reddy et al. 1990 ). The second construct (NGFRtl68) encoded the first 168 amino acid residues of the LNGFR, encompassing only the four cysteine-rich sequences (figure 1). When mouse fibroblast cells were transfected with this construct, a secreted form of the receptor, with an A/4 of 48000 was found in the supernatant. Since this form of the receptor bound NGF (figure 2), it is clear that the four cysteine-rich blocks comprise a major part of the NGF binding site. Further mutations were made by removing sequentially, blocks, or parts of blocks from the amino terminus of the LNGFR (figure 1). All the mutant LNGFRs were expressed in COS cells at equivalent levels, as determined by immunoblotting using an antipeptide antibody which recognizes an intracellular epitope of the LNGFR (D. Shelton, personal communication). As judged by cross-linking of 125I-NGF, the mutants lacking the first block (NHD 1) or the first and part of the second block (NHD 2) retained NGF binding activity, although at a much lower level than the wildtype receptor, whilst the mutant lacking all four blocks (NHD 3) failed to bind NGF. Although the cross-linking method of measuring NGF binding is not quantitative and is subject to variability within the mutants, this data does suggest that multiple elements in the four cysteine-rich blocks create the NGF-binding site.
ISOLATION OF GENES WHOSE EXPRESSION IS REGULATED AFTER SCIATIC NERVE INJURY
It is clear that there are molecules other than NGF and its receptor involved in the process of nerve regeneration (Skene & Shooter 1983; Muller et al. 1986; Trapp et al. 1988; Meier et al. 1989) . To extend these studies, we examined the extent of gene regulation during regeneration. This section describes the use of differential hybridization to identify genes whose expression is regulated during regeneration. It is likely that the proteins encoded by these genes will have some function during regeneration. By only limiting the screen to genes that are regulated, it was anticipated that the procedure would isolate both known and unknown genes.
The principal of differential hybridization as applied to nerve regeneration is diagrammed in figure 3 . This example shows the isolation of induced sequences. The upper part shows the gene expression before and after nerve injury. After nerve injury, some mRNA species will be increased, e.g. mRNA B. RNA is isolated from injured and uninjured nerves, and a cDNA library made from the RNA from the injured nerve (middle right). Duplicate filters containing individual colonies are screened with 32P-labelled cDNA made from RNA from uninjured or injured nerves (bottom part). Colonies containing sequences whose expression is induced during regeneration will hybridize more of the 32P-labelled cDNA from the injured than from the uninjured nerve. The cloned sequences can then be analysed to try to determine the function of the regulated, encoded proteins during regeneration. Accordingly, two cDNA libraries from the sciatic nerve of rats were constructed and screened (De Leon et al. submitted manuscript) . The first cDNA library was prepared by using RNA from the distal segment of the sciatic nerve, three days after a crush injury. This cDNA library is referred to as the distal library (DL), and it was constructed to identify sequences whose expression is induced during nerve regeneration. A second cDNA library was constructed by using RNA from the uninjured contralateral nerves of the same pool of animals used for the first library. This contralateral library (CL) served for the isolation of sequences whose expression is repressed during nerve regeneration.
Both libraries were screened by differential hybrid ization to identify clones containing sequences which were regulated during nerve regeneration. Figure 4 shows representative duplicate filters after the second round of screening. The particular filters shown were from the crushed nerve library, and were used to identify sequences whose expression was induced after sciatic nerve injury. Several examples of increased hybridization to colonies on the right filter (32P-labelled crushed nerve cDNA), as compared to hybridization to colonies on the left filter (32P-labelled contralateral nerve cDNA), can be seen. A total of 2000 colonies were screened from the DL, and 11 colonies were isolated that contained sequences induced during neuronal regeneration. A total of 5000 colonies of the CL library were also screened by differential hybridization. After two rounds of screening, 30 colonies contained sequences whose expression was repressed three days after nerve crush.
The cDNA inserts in these colonies were tested by cross-hybridization analysis to identify related, homo logous sequences within all of the isolated sequences. Unique clones from each group were partially sequenced, and the sequences were compared to the GenBank and EMBL DNA sequence databases. A summary of the identity of the induced and repressed sequences is shown in table 1. Four of the induced sequences were homologous to vimentin, five were homologous to rRNA, and two were not homologous to any sequences in the database (novel sequences).
The induction levels were 3-5-fold for all sequences mentioned in table 1. Similarly, the identity of the repressed, isolated sequences are shown in table 1. Numerous known sequences were isolated including myelin P0, alphaglobin, myelin basic protein, cytochrome oxidase (subunit I), skeletal muscle creatine kinase (M creatine kinase), and collagen (type alpha-1). Also, five groups of novel sequences, as determined by cross-hybrid ization studies, were isolated. The extent of repression of these sequences ranged from 3-fold to more than 10-fold.
Next, the isolated sequences were tested by northern blot analysis to determine the regulation of their expression throughout the degeneration and regen eration process. The results can be summarized as follows. One group of sequences, such as vimentin, showed an increase in their expression on the crush side, compared to the contralateral side, during the first few days after nerve crush, after which expression gradually returned to a normal level after two or three weeks. The second group of sequences, such as myelin P0, showed a strong decrease in their expression on the crush side, as compared to the contralateral side, within a day after nerve injury, but eventually increased to normal levels, several weeks after the nerve crush. The last group of sequences, such as SR 7, showed complex regulation, including oscillating gene expression throughout the degeneration and regeneration process.
The induction or repression during neuronal re generation of the specific sequences reported here was assessed by the comparison of the crushed and uninjured, contralateral nerves of the same animals. During the analysis, however, it became clear that there was a second level of regulation operating, when the expression was compared between operated and unoperated, naive animals. This effect can be small for genes such as myelin P0, or large, as observed for genes such as SR 7. It has been previously shown, that the sciatic nerve lesion produces changes in the contra lateral, uninjured nerve (Rotshenker 1988) . At present, it is not clear if the second level of regulation seen here is the same as the previously described contralateral effect, or is due to systemic effects of the surgery. Whatever the explanation, it is of interest that the time course of the effects reported here parallel the timecourse of neuronal degeneration and regeneration, suggesting that these effects are specific to .the injured and uninjured nerves.
The next step in this process is to identify the role these proteins may play during regeneration. Studies in other systems on some of the isolated, known genes suggest possible roles. For example, the expression of creatine kinase mRNA is regulated during the process of myogenesis. Creatine kinase RNA is not expressed in myoblasts at the time when they are undifferentiated and are still proliferating. However, both the RNA and protein level of creatine kinase M increase when myoblast fusion occurs (Trask et 1988) . Studies with the BC3H1 muscle cell line showed that the expression of creatine kinase M mRNA increased several hundred fold in tissue culture conditions that stimulate differ entiation and cessation of proliferation (Spizz et at. 1986) . However, when these differentiated, quiescent cells were stimulated to divide with fibroblast growth factor (FGF) or media containing 20% serum, the expression of creatine kinase M was repressed. It is intriguing that during sciatic nerve regeneration, the repression of creatine kinase parallels the initial proliferation of Schwann cells, followed by their later differentiation. Schwann cells may use creatine kinase M during normal metabolism, but then switch to a different energy pathway during proliferation.
Finally, it is worth noting that 13 out of the 41 sequences examined in this work represent unknown sequences, corresponding to as yet unknown genes which may play a role in neuronal degeneration and regeneration. Clearly, the regeneration process is quite complex at the molecular level.
